This NDC is on FDA's drug shortage list (posted Nov 4, 2024)
Reported reason: Other
Product Information
HYDROXOCOBALAMIN 1,000 MCG/ML is a generic product labeled by Actavis Pharma, Inc., priced at $0.8144 per ML under NDC 00591288830. Its NADAC has been published 293 times since Nov 28, 2013.
FDA first approved this application before 1982.
Strength
1000 ug/mL
Manufacturer
Actavis Pharma, Inc.NDC
00591288830
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Effective Date
3/18/2026
Active Ingredients
HYDROXOCOBALAMIN ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA085998FDA Approved
Before 1982
On Market Since
11/12/2010
Pharmacological Classes
Price Statistics
The NADAC for HYDROXOCOBALAMIN 1,000 MCG/ML has been published 293 times since Nov 28, 2013, and over the history we have for it it has declined 5.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8144 per ML |
|---|---|
| All-time high | $0.9053 (Jul 16, 2014) |
| All-time low | $0.7953 (Feb 19, 2025) |
| 52-week high | $0.8223 |
| 52-week low | $0.8144 |
| Median price | $0.8415 |
| Average price | $0.8402 |
| Largest weekly change | -6.4% (Oct 22, 2014) |
| Weeks tracked | 293 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydroxocobalamin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydroxocobalamin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antidote class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROXOCOBALAMIN 1,000 MCG/ML?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXOCOBALAMIN 1,000 MCG/ML, manufactured by Actavis Pharma, Inc., is $0.8144 per ML (NDC 00591288830), effective Sep 30, 2026.
How has the price of HYDROXOCOBALAMIN 1,000 MCG/ML changed over time?
Over the history we have for it, the NADAC for HYDROXOCOBALAMIN 1,000 MCG/ML has declined 5.2%. It has been tracked across 293 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROXOCOBALAMIN 1,000 MCG/ML?
Since Nov 28, 2013, the NADAC for HYDROXOCOBALAMIN 1,000 MCG/ML has ranged from a low of $0.7953 (Feb 19, 2025) to a high of $0.9053 (Jul 16, 2014), with a median of $0.8415 per ML.
Are there cheaper alternatives to HYDROXOCOBALAMIN 1,000 MCG/ML?
No other NADAC-published product currently shares the active ingredient and strength of HYDROXOCOBALAMIN 1,000 MCG/ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROXOCOBALAMIN 1,000 MCG/ML?
HYDROXOCOBALAMIN 1,000 MCG/ML (NDC 00591288830) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Is HYDROXOCOBALAMIN 1,000 MCG/ML in shortage?
Yes — NDC 00591288830 is currently listed in FDA's drug shortage database (posted Nov 4, 2024). Reported reason: Other.